ANN ARBOR - CytoPherx announced it has closed a $34 million funding round that will be used to complete U.S. clinical trials and gain FDA approved for the anti-inflammatory therapy for acute kidney injury. A large syndicate of investors co-led by Early Stage Partners, Onset Ventures and Capital Midwest Fund, participated in the round. Dr.
GRAND RAPIDS - The Van Andel Education Institute has signed an agreement with United Negro College Fund to cooperatively recruit students at historically black institutions interested in research training in the biomedical sciences, specifically in the cellular, molecular, and genetic biology of human disease. Under the terms of the joint initiative, UNCF and VAEI will
KALAMAZOO - NephRx Corporation Wednesday announced the issuance of U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis and other diseases of the gastrointestinal tract. This new patent follows an NX002 patent for inflammatory bowel disease issued earlier this year. Previously, NephRx reported that NX002
SOUTH SAN FRANCISCO - BioSeek, LLC, a subsidiary of Asterand plc, announced Wednesday that the first research milestone has been achieved in the multi-year drug discovery collaboration with Ono Pharmaceutical Co. BioSeek is applying its proprietary BioMAP platform to perform phenotypic screening, hit identification, lead optimization and clinical candidate selection on a target selected by
GRAND RAPIDS ? Van Andel Research Institute and Helen DeVos Children's Hospital Thursday announced participation in a Dell-funded national initiative based on technology developed by VARI and tested in collaboration with Spectrum Health to support a personalized medicine trial for pediatric cancer. The Dell-funded research will be conducted by the Neuroblastoma and Medulloblastoma Translational Research
GRAND RAPIDS ? Bioscience trade association MichBio on Thursday presented its "Legislator of the Year" award to U.S. Rep. Mike Rogers, a Republican from Michigan's 8th District, for providing leadership on legislative issues important to the biosciences industry. The award was presented on the second day of the MichBio Expo. Stephen Rapundalo, Ph.D., President and
ANN ARBOR - Kai Yang, professor in the Department of Industrial and Manufacturing Engineering at Wayne State University, will discuss important success factors for industrial engineering to effectively improve the healthcare industry's performance Nov. 7 at Cleary University. The American healthcare industry is facing challenges because of increasing healthcare cost, dissatisfaction with healthcare quality, and
GRAND RAPIDS - The MichBio Expo & Conference was already the largest gathering of bioscience professionals in the state attracting approximately 500 participants and more than 50 exhibitors Nov. 2-3 at DeVos Place. Now MichBio includes exclusive Grand Rapids bioscience facility tours. In addition to co-sponsoring the expo, WMSTI will be a venue for the
DETROIT - RetroSense Therapeutics announced that it has executed its exclusive, worldwide option and signed a license agreement for novel gene-therapy approaches for treating blindness developed at Wayne State University's School of Medicine. Zhuo-Hua Pan, Ph.D., professor of anatomy and cell biology in the School of Medicine, along with colleagues at Salus University in Pennsylvania,
ANN ARBOR - The Advanced Medical Technology Association has named Stephen Rapundalo, Ph.D., president and CEO of MichBio, chair of its State Medical Technology Alliance. The mission of the alliance, a national network of associations representing medical device manufacturers affiliated with AdvaMed, is to collectively support the industry by fostering a collaborative environment through sharing